Accumulation of fibrin in the blood vessels usually results in thrombosis, leading to
myocardial infarction and other cardiovascular diseases. For thrombolytic therapy, microbial …

Cardiac disorders such as acute myocardial infarction, embolism and stroke are primarily
attributed to excessive fibrin accumulation in the blood vessels, usually consequential in …

Thrombosis has threatened human health in past decades. Bacillus nattokinase is a
potential low-cost thrombolytic drug without side-effects and has been introduced into the …

Cardiovascular diseases, such as heart attack and stroke, are the leading causes of death in
North America. According to data provided by the World Health Organization in 2000, heart …

Fibrinolytic enzymes are important in treatment of cardiovascular diseases. The present
work reports isolation, screening and identification of marine cultures for production of …

Bacillus subtilis natto B-12 was isolated from natto, a traditional fermented soybean food in
Japan. A fibrinolytic enzyme (B-12 nattokinase) was purified from the supernatant of B …

Conversion of fibrinogen to fibrin inside blood vessels results in thrombosis, leading to
myocardial infarction and other cardiovascular diseases. In general, there are four therapy …

Enzyme therapies are attracting significant attention as thrombolytic drugs during the current
scenario owing to their great affinity, specificity, catalytic activity, and stability. Among various …

Reports of the beneficial health effects of some peptides have begun to make their way into
the scientific literature. Peptides can act as immunomodulators, and have been shown to …

A novel fibrinolytic enzyme was purified from fermented shrimp paste, a popular seasoning
used in Asian countries. The enzyme is a monomer with an apparent molecular weight of 18 …